Fleury J, Bonnet M
Clinique Ophtalmologique de la Croix-Rousse.
Bull Soc Ophtalmol Fr. 1990 Apr;90(4):433-5.
Perfluoropropane gas as an adjunct to vitreoretinal microsurgery in the management of proliferative vitreoretinopathy. Pure perfluoropropane gas was used as an adjunct to vitreoretinal microsurgery in 60 eyes of 60 patients with rhegmatogenous retinal detachment complicated by proliferative vitreoretinopathy. 0.3 ml to 1.8 ml (average 0.9 ml) of pure perfluoropropane gas were used. The surgical procedure included a vitrectomy and a scleral buckling procedure in all patients. The follow-up after complete gas absorption ranges from 6 months to 3 years in the successful eyes. Total retinal reattachment was achieved in 41 eyes (68.3%). The anatomical success rate was 88% (22/25 eyes) in grade C1-C2 PVR cases, 68.7% (11/16 eyes) in grade C3-D1 PVR cases, and 42% (8/19 eyes) in grade D2-D3 PVR cases. Visual acuity of 0.1 or better was achieved in 80% of eyes with grade C PVR and 61% of eyes with grade D PVR. Visual acuity of 0.4 or better was achieved in 26.9% of eyes with grade C PVR. Macular changes were revealed by fluorescein angiography in 53% of successful eyes. We recommend the use of C3F8 rather than SF6 in the management of rhegmatogenous retinal detachment complicated by PVR. In our experience the anatomical success rate achieved with C3F8 is approximately the same as that achieved with SF6. However permanent retinal reattachment was achieved with a single operation in 87.8% of successful eyes of the present series of patients manages with C3F8 as compared to only 12% of successful eyes of a previous series of patients managed with SF6.(ABSTRACT TRUNCATED AT 250 WORDS)
全氟丙烷气体作为增殖性玻璃体视网膜病变治疗中玻璃体视网膜显微手术的辅助手段。60例孔源性视网膜脱离合并增殖性玻璃体视网膜病变患者的60只眼中,使用纯全氟丙烷气体作为玻璃体视网膜显微手术的辅助手段。使用的纯全氟丙烷气体量为0.3毫升至1.8毫升(平均0.9毫升)。所有患者的手术步骤包括玻璃体切除术和巩膜扣带术。成功眼在气体完全吸收后的随访时间为6个月至3年。41只眼(68.3%)实现了视网膜完全复位。C1 - C2级增殖性玻璃体视网膜病变(PVR)病例的解剖成功率为88%(22/25只眼),C3 - D1级PVR病例为68.7%(11/16只眼),D2 - D3级PVR病例为42%(8/19只眼)。C级PVR的眼中80%视力达到0.1或更好,D级PVR的眼中61%达到该视力。C级PVR的眼中26.9%视力达到0.4或更好。53%的成功眼中荧光素血管造影显示有黄斑改变。我们建议在治疗孔源性视网膜脱离合并PVR时使用C3F8而非SF6。根据我们的经验,C3F8取得的解剖成功率与SF6大致相同。然而,本系列使用C3F8治疗的成功眼中,87.8%通过单次手术实现了永久性视网膜复位,而之前使用SF6治疗的系列成功眼中只有12%达到这一效果。(摘要截短于250字)